Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$2.47 USD
+0.14 (6.01%)
Updated Aug 11, 2025 04:00 PM ET
After-Market: $2.46 -0.01 (-0.40%) 5:34 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Autolus Therapeutics PLC Sponsored ADR has a market cap of $620.11M, which represents its share price of $2.33 multiplied by its outstanding shares number of 266.14M. As a small-cap company, AUTL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AUTL 2.47 +0.14(6.01%)
Will AUTL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AUTL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AUTL
Autolus Therapeutics Q2 2025 Earnings Preview
Autolus Therapeutics PLC (AUTL) Q2 2025 Earnings Report Preview: What To Look For
Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call ...
Analyst Reiterates Buy Rating on Autolus Therapeutics (AUTL) | AUTL Stock News